H ydroxyurea, the simplest, 1-carbon organic antitumor agent, is a member of the substituted urea group and is chemically known as hydroxycarbamide (1) . First synthesized in 1869, it produced leukopenia and changes in the bone marrow. In 1981 it was reported to have antineoplastic activity against sarcoma (2) . At present, the primary role of hydroxyurea in chemotherapy is the management of granulocytic leukemia and thrombocytosis. It has been used in combination with radiotherapy for carcinomas of the head and neck (3) . It is official in the British, U.S., and French Pharmacopeias.
Several procedures have been reported for determination of hydroxyurea: nuclear magnetic resonance spectroscopy (4), hydroxyl value determination (5), spectrophotometry with different metals (6) (7) (8) and reagents (9) (10) (11) , and titrimetric procedures that involve acidimetry after its reduction to ammonia (12) , iodometry (13) , permenganometry (14) , and reductimetry with ferrous ions (15) .
Liquid chromatographic (LC) procedures have been recommended by the U.S. Pharmacopeia (16) and others (17) (18) (19) for determination of hydroxyurea in pharmaceutical formulations and biological fluids. Capillary gas chromatography (GC) with thermionic (N-P) specific detection has also been reported (20) .
One potentiometric method has been recommended for hydroxyurea determination by iodide-ion selective electrode (21); 2 fluorimetric procedures using luminal/Cu(II) ions (22) and 2-hydroxybenzaldelyde azine (23) have also been reported. Most of these methods involve time-consuming procedures, derivatization with complicated reactions, or use of sophisticated instruments. Of all these procedures only the capillary GC technique has been recommended as a stability-indicating assay, but it is not yet available in many control laboratories, especially in developing countries. It is necessary, therefore, to develop simple and sensitive stability-indicating procedures for the assay of hydroxyurea.
It is well known that hydroxyurea is rapidly destroyed by heating at extreme pH, with hydroxylamine as the main degradation product (24) . A stability study showed that the drug was unstable in aqueous solution even at 4°C (20) ; it degrades with the production of hydroxylamine, which is a dangerous carcinogenic agent (25) .
The proposed potentiometric methods make use of the application of functionalized lipophilic cyclodextrins as sensor ionophores in the preparation of hydroxyurea-sensitive electrodes with carboxylated polyvinyl chloride (PVC-COOH) as polymeric matrix and either tetrakis (p-chlorophenyl) borate (TClPB), or tetrakis [3,4-bis (trifluoromethyl) phenyl] borate (TFPB) as a fixed anionic site in procedures 1 or 2, respectively.
The proposed fluorimetric methods use the drug-metal complexes that emit fluorescence at l380 and l355 nm after excitation at l305 nm with Al(III) and Mg(II) ions used for procedures 3 and 4, respectively. 
METHOD

Equipment
Reagents and Solutions
All reagents were analytical grade and used without additional purification.
( for aluminum complex and magnesium complex, respectively, where C = concentration of hydroxyurea in mg/mL and F = intensity of fluorescence.
(b) Application to capsules.-Mix and weigh contents of 5 capsules. Weigh portion of powder equivalent to ca 100 mg hydroxyurea, dissolve in 70 mL water, and shake well for 15 min. Filter and dilute to 100 mL with water. Complete as detailed for Al and Mg, above.
(c) Application to biological fluids.-Adjust urine to pH 10 and serum to pH 7. Place 5 mL serum or urine in 50 mL stoppered shaking tube. Add 1 mL standard drug stock solution, followed by 20 mL toluene for urine or 20 mL diethyl ether for serum. Shake tube 10 min and centrifuge. Reject organic layer. Transfer aqueous layer to another shaking tube containing 10 mL butanol. Shake 10 min, centrifuge, and evaporate organic layer under vaccum. Transfer complex to 100 mL volumetric flask, and dilute to volume with water. Apply above fluorimetric procedures by using 3, 4, and 5 mL of this solution.
(d) Application to synthetic mixtures with degradate.-Into series of 100 mL volumetric flasks, accurately transfer 25, 50, and 75 mL working hydroxyurea solutions (5´10 -3 or 10´10 -3 mg/mL for method 3 or method 4, respectively). Dilute to volume with 75, 50, and 25 mL hydroxylamine solution of the same potency (5´10 -3 or 101 0 -3 mg/mL for method 3 or method 4, respectively) and shake. Into series of 10 mL volumetric flasks, transfer 5 mL of each of the previous solutions and complete as detailed for Al and Mg, above.
The 4 suggested procedures were compared with the USP method in which degassed water is the mobile phase, uracil is the internal standard, and 0.5 mL/min is the flow rate. The rel- ative responses were measured by using a 214 nm detector. The relative retention times were ca 0.5 for hydroxyurea and 1.0 or uracil.
Results and Discussion
Cyclodextrins are optically active oligosaccharides that form inclusion compounds in aqueous solution and in solid state with organic molecules, because their chemical structure provides well-defined inclusion cavities with a specific receptor function (26) . b-cyclodextrins were previously applied as sensor ionophores to potentiometric ion-selective electrodes for determination of onium ions (27) , chiral molecules incorporating aryl rings (28) , and protonated amines (29) .
The present work evaluates the possibility of using b-cyclodextrin as ionophore in the preparation of hydroxyurea-selective electrodes in which carboxylated PVC was used as polymeric matrix for immobilization of the sensor. This is intended to promote full saturation of the primary hydroxyl groups at the C-6 positions of the b-cyclodextrin molecule and thus attain high stability of the complex between that molecule and the protonated hydroxyurea ion present in the solution (29) . Minimal interference from degradate of hydroxyurea (hydoxylamine) and other urea derivatives was obtained when NPPE was used as plasticizer and a tetraphenylborate derivative was used as a fixed anionic site.
The fluorimetric methods depend on hydroxamide group (O=C-NH-OH), which is present in the molecule of hydroxyurea and absent in the molecule of its degradate. This group is essential for tight binding between hydroxyurea molecule and metal ions (30, 31) . It is also essential for irreversible formation of that complex. On the other hand, the hydroxylamine molecule would form only loose complexes with metal ions, which are devoid of fluorescence.
Electrodes Behavior
The general working characteristics of the electrodes were evaluated by regular calibrations (Figure 1) , and the critical electrochemical performance characteristics of the sensors were systematically evaluated according to International Union of Pure and Applied Chemistry (IUPAC) recommendations (32) . Table 1 shows the data collected over 2 months from 6 different assemblies of each type of sensor. The sensor displayed constant potential readings within ±1 mV from day to day, and from one instrument to another [Orion Model 720A and Jenway Model 720]. The results obtained with 6 different assemblies of each sensor revealed interbatch precision within ±1 mV/decade and potential accuracy within ±0.5 mV.
Although the electrode prepared with TFPB had response characteristics similar to those with TClPB (Table 1) , the first electrode with the larger TFPB molecule shows longer life time, higher selectivity, and better reproducibility than the second electrode with the smaller TClPB molecule. The effect of pH on electrode responses was evaluated on 10 -3 M drug concentration, using acetate buffer. The results plotted show an operational pH range of about 3-6 ( Table 1 ). The range of interference provided by different inorganic and organic ions was assessed by determining the potentiometric selectivity coefficients, using the separate selectivity method (SSM; 32). No significant interference was observed from the studied ions (Table 2), especially hydroxylamine and other urea derivatives. Although the concentration of tetraphenylborate derivative does not affect membrane potential, we found that decreasing the ionophore concentration led to decreasing the membrane potential, and, thus, to fewer Nernstian responses. The use of a solvent with high dielectric constant, such as NPPE (33) , facilitated the inclusion of organic interferents by competitive inclusion.
Nernstian responses were obtained in the range of 10 Because of the semilogarithmic relation between drug concentrations and mV, it was recommended that a suitable method for obtaining lower limit of detection (LLD) in potentiometric procedures is the extrapolation of calibration graphs (32) . Thus, the LLD was taken at the point of intersection of the extrapolated linear mid-range and final low concentration level segments of the calibration plot.
Spectrofluorimetric Investigation
Both hydroxyurea and its degradate, hydoxylamine, showed no native fluorescence, but hydroxyurea reacted with aluminum chloride and magnesium sulfate to produce colorless complexes that fluoresced at l380 and 355 nm when excited at l305 nm, respectively (Figure 2 ). Job's method (34) of continuous variation is reported to be valid in both spectrophotometric and fluorimetric procedures (31) . Thus, it was applied in order to study the stoichiometry of the reaction between hydroxyurea and Al(III) or Mg(II). Results revealed a 1:1 complexation ratio in both cases under the optimum conditions attained for the reaction between the drug and the metal ions. Although hydroxyurea makes coordination complexes of mono (hydroxyureate) Al(III) or Mg(II) with a concomitant loss of proton, hydroxylamine does not undergo this complexation reaction. The hydroxamide group, which is present in the hydroxyurea molecule and absent in the hydroxylamine molecule, is essential for both tight binding and irreversibility of that complex formation.
In order to establish the optimum pH for this complexation reaction, hydroxyurea was allowed to react with aluminum chloride and magnesium sulfate in aqueous solutions buffered to pH 3-8. Maximum fluorescence was obtained with McIlvaine standard buffer solution at pH 5.The volume of the buffer was optimized at 2 mL.
The effect of time on the intensity of fluorescence of the drug-metal complexes was also studied. It was found that maximum fluorescence occurred for Al(III) complex after 30 min and was stable for another 30 min, whereas the Mg(II) complex showed maximum fluorescence after 15 min and was stable for 90 min (Figure 3) . The complexes were stable at different temperatures up to 60°C.
By applying the optimum experimental conditions, we developed standard calibration curves for drug-metal complexes.
Linear correlations were obtained between fluorescence intensities and concentrations in the range of 0.5-2.5 mg/mL for drug-Al(III) complex and 1-5 mg/mL for drug-Mg(II) complex.
To apply the investigated methods on biological fluids, toluene and diethylether were added for deprotonation of urine and serum, respectively. Although a further extraction procedure was necessary for applying the proposed fluorimetric methods, no extraction was needed for applying the selective potentiometric methods.
Analytical Applications
The 4 developed procedures showed working characteristics adequate for determination of hydroxyurea in pharmaceutical preparations, biological solutions, and synthetic mixtures with its degradate. Table 3 shows the potentiometric and fluorimetric results obtained for determination of hydroxyurea in capsules, on samples previously prepared. It also shows good agreement between the proposed and the USP (16) procedures.
The recovery values and the relative standard deviations, which were calculated after standard additions, are also presented in Table 3 . Average recoveries of 100.2 ± 0.18 and 99.4 ± 1.50% were obtained for the proposed potentiometric and fluorimetric methods, respectively. Table 4 shows results obtained from the determination of hydroxyurea in spiked human urine and serum. Average recoveries of 99.7 ± 0.99 and 99.4 ± 1.38% were obtained for the potentiometric and fluorimetric methods, respectively. The spiked drug amounts in potentiometric and fluorimetric methods were dependent on the concentration ranges of each procedure. Although both proposed procedures were successfully applied to biological fluids, the potentiometric method showed wider concentration range and more sensitive results than did the fluorimetric method. Table 5 shows the results obtained from the determination of hydroxyurea in laboratory-prepared mixtures with hydroxylamine. Hydroxylamine had no significant effect on the response of the proposed sensors (average recovery was 99.5 ± 0.38%) and no interfering fluorescence at l380 or l355 nm after excitation at l305 nm (average recovery was 99.8 ± 1.56%). The 4 proposed methods are stability-indicating.
Conclusions
The results of this study show that the 2 constructed electrodes presented suitable responses for analytical use. Apart from presenting linear responses within wide pH and concentration ranges with high sensitivity, they also had high selectivity and reproducibility. The proposed flourimetric methodology is advantageous because it is satisfactory, reliable, sensitive, and selective.
The described potentiometric and spectrofluorimetric methods have simple work-up procedures, require no sophisticated instrumentation, and determine only the therapeutically active, undegraded drug. They offer distinct advantages in rapidity and simplicity and could be used in quality control laboratories, especially those of developing countries. These aspects are justified by the results obtained from the analysis of capsules, biological fluids, and laboratory-prepared mixtures with hydroxylamine, with which precise and accurate recoveries were obtained.
